Clinical Trials

S1011: Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer (H-29212)

S1011: Phase III Surgical Trial to Evaluate the Benefit of A Standard Versus An Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy For Muscle Invasive Urothelial Cancer (H-29212): 

This study will investigate whether patients experience longer disease-free survival when they undergo the standard surgical treatment alone or the standard surgical treatment and the removal of additional lymph nodes. Patients must have certain confirmed stages of urothelial carcinoma of the bladder that requires radical cystectomy for treatment. Patients will be randomized to one of the treatment options during the surgical procedure and be followed for 6 years from the time of surgery. 

For more information: